Biotechnologist

Health Researcher

2003: Master’s Degree (M.Sc.) in Biotechnology at University of Bologna (107/110)

2010: Doctor of Philosophy (Ph.D.) in “Pathology and Molecular Epidemiology of Implant associated Infections” (Microbiology area)

• 2019-up to present: Health Researcher (Research Unit on Implant Infection of IOR).
• 2015-2019: Biotechnologist Researcher (Research Unit on Implant Infection of IOR).
• 2010-2015: Post-doctoral Researcher (Research Unit on Implant Infection of IOR and University of Bologna).
• 2006-2010: Contract Researcher and Ph.D. Student (Research Unit on Implant Infection of IOR and University of Bologna).
• 2005-2006: Research Grant (Laboratory of Cell Biology and Electron Microscopy of IOR).
• 2004: Contract Researcher (European Foundation of Oncology and Environmental Sciences B. Ramazzini).

Italian: mother tongue
English: fluent

Participation in various research projects.
Publications: 35 (6 first name). H-index: 18. i10-index:27 (from Scholar Google). https://scholar.google.it/citations?hl=it&user=8E_Bg74AAAAJ&view_op=list_works&sortby=pubdate 
https://sciprofiles.com/profile/193951
https://publons.com/researcher/1171655/stefano-ravaioli/
Participation at the editorial boards of various scientific journals as Topic and Guest Editor, and Reviewer.

Pathogenesis of the implant-associated infections, the role of new emerging opportunistic pathogens and their characterization in term of genetic diversity and virulence factors (i.e., studies on biofilm; bacterial invasiveness; genetic detection of adhesins, toxins, IS256, and antibiotic resistance traits). Molecular epidemiology studies such as the identification of new emerging or the most prevalent bacterial clones through genotypic characterization (automated Ribotyping, MLST, spa typing, SCCmec typing, agr typing, PFGE, NGS). 
Studies of the pathological interactions between bacteria with eukaryotic cells; the study of behaviour and interactions of eukaryotic cells exposed to anti-infective substances; significance of new strategies based on the use of anti-infective (natural substances, phytocompounds or antibacterial peptides) to prevent the bacterial adhesion and colonization.